Sexually Transmitted Disease Screening
Detection and typing of Human Papillomavirus (HPV)
$1,650 MXN
- 44 viral subtypes analyzed
- High risk (HR):16, 18, 26, 31, 33, 34, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 67, 68, 70, 73 and 82
- (BR): 6, 11, 13, 32, 40, 42, 43, 44, 54, 55, 57, 61, 62, 64, 69, 71, 72, 81, 83, 84, 87, 89 y 90
- Technique: PCR. Type: qualitative (detection)
Sexually Transmitted Disease Panel (STD-3)
$1,890 MXN
- Herpes Simplex Virus 1
- Herpes Simplex Virus 2
- Chlamydia trachomatis
Sexually Transmitted Disease Panel (STD-4)
$2,350 MXN
- Human papillomavirus (HPV) 44 subtypes
- Chlamydia trachomatis
- Herpes Simplex Virus 1
- Herpes Simplex Virus 2
Panel de Enfermedades de Transmisión Sexual (ETS-6) HOMBRE
$2,400 MXN
- Human papillomavirus (HPV) 44 subtypes
- Herpes Simplex Virus 1
- Herpes Simplex Virus 2
- Mycoplasma genitalium
- Ureaplasma urealyticum
- Neisseria gonorrhoeae
Sexually Transmitted Diseases Panel (STD-7)
$2,700 MXN
- Human papillomavirus (HPV) 44 subtypes
- Chlamydia trachomatis
- Herpes Simplex Virus 1
- Herpes Simplex Virus 2
- Neisseria gonorrhoeae
- Trichomonas vaginalis
- Mycoplasma genitalium
Sexually Transmitted Disease Panel (STD-8)
$3,000 MXN
- Human papillomavirus (HPV) 44 subtypes
- Neisseria gonorrhoeae
- Herpes Simplex Virus 1
- Herpes Simplex Virus 2
- Mycoplasma genitalium
- Trichomonas vaginalis
- Ureaplasma urealyticum
- Chlamydia trachomatis
Sexually Transmitted Disease Panel (STD-11)
$3,100 MXN
- Human papillomavirus (HPV) 44 subtypes
- Neisseria gonorrhoeae
- Herpes Simplex Virus 1
- Herpes Simplex Virus 2
- Mycoplasma genitalium
- Trichomonas vaginalis
- Ureaplasma urealyticum
- Chlamydia trachomatis
- Treponema pallidum
- Mycoplasma Hominis
- Ureaplasma parvum
Process for performing the study
At Genolife, we perform virus detection from samples obtained through urethral and cervicovaginal exudate.
Técnica: PCR (reacción en cadena de la polimerasa) VPH genotipado (21AR Y 23 BR)
Type: qualitative (detection)
Indicaciones para la toma de muestra exudado uretral o cervicovaginal (VPH / ETS):
No usar óvulos, cremas ni duchas vaginales por lo menos 24 horas antes.
No usar medicamentos tópicos en la zona a evaluar por lo menos 24 horas antes.
No tener relaciones sexuales 72 horas previas a la toma.
No realizar aseo íntimo agresivo el día de la toma.
En hombres, se indica no orinar al menos 2 hora antes de la toma uretral.
En caso de estar en tratamiento antibiótico, esperar al menos 7 días después de terminarlo para tomar la muestra.
Contact us to schedule your appointment